The current state of nonuremic applications for extracorporeal blood purification

Seminars in Dialysis

Volumn 18, Issue 5, 2005, Pages 380-390

  Briglia, Andrew E ^a,b  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MARYLAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOPULMONARY BYPASS; CONGESTIVE HEART FAILURE; ELECTROLYTE BALANCE; HUMAN; KIDNEY FAILURE; LACTIC ACIDOSIS; LIVER FAILURE; PATHOPHYSIOLOGY; RENAL REPLACEMENT THERAPY; REVIEW; RHABDOMYOLYSIS; SEPSIS; THERMOREGULATION; TUMOR LYSIS SYNDROME; UREMIA;

ACIDOSIS, LACTIC; BODY TEMPERATURE REGULATION; CARDIOPULMONARY BYPASS; HEART FAILURE, CONGESTIVE; HUMANS; KIDNEY FAILURE; LIVER FAILURE; RENAL DIALYSIS; RHABDOMYOLYSIS; SEPSIS; TUMOR LYSIS SYNDROME; UREMIA; WATER-ELECTROLYTE BALANCE;

EID: 27544456847     PISSN: 08940959     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1525-139X.2005.00076.x     Document Type: Review

References (199)

1. Carpenter WT Jr, Sadler JH, Light PD, Hanlon TE, Kurland AA, Penna MW, Reed WP, Wilkinson EH, Bartko JJ: The therapeutic efficacy of hemodialysis in schizophrenia. N Engl J Med 308:669-675, 1983
2. Nissenson AR, Rapaport M, Gordon A, Narins RG: Hemodialysis in the treatment of psoriasis. A controlled trial. Ann Intern Med 91:218-220, 1979
3. Ranson JH, Rifkind KM, Turner JW: Prognostic signs and nonoperative peritoneal lavage in acute pancreatitis. Surg Gynecol Obstet 143:209-219, 1976
4. Ranson JH, Berman RS: Long peritoneal lavage decreases pancreatic sepsis in acute pancreatitis. Ann Surg 211:708-716, 1990
5. Rodby RA: Nonuremic uses for dialysis. Semin Dial 8:314-319, 1995
6. Twardowski ZJ, Lempert KD, Lankhorst BJ, Welton WA, Whittier FC, Anderson PC, Nolph KD, Khanna R, Prowant BF, Schmidt LM: Continuous ambulatory peritoneal dialysis for psoriasis. A report of four cases. Arch Intern Med 146:1177-1179, 1986
7. Vanherweghem JL, Linkowski P, Mendlewicz J: Hemodialysis in schizophrenics. A double-blind study. Arch Gen Psychiatry 40:211-214, 1983
8. Wagemaker H, Rogers JL, Cade R: Schizophrenia, hemodialysis, and the placebo effect. Results and issues. Arch Gen Psychiatry 41:805-810, 1984
9. Whittier FC, Evans DH, Anderson PC, Nolph KD: Peritoneal dialysis for psoriasis: a controlled study. Ann Intern Med 99:165-168, 1983
10. Schetz M: Non-renal indications for continuous renal replacement therapy. Kidney Int Suppl 72:S88-S94, 1999
11. Ronco C: Complications of RRT in the ICU. In: Lamiere N, Mehta RL (eds). Complications of Dialysis. New York: Marcel Dekker, 2000:625-641
12. Leunissen KML, Kooman JP, van der Sande FM: Acute dialysis complications. In: Lamiere N, Mehta RL (eds). Complications of Dialysis. New York: Marcel Dekker, 2000:69-88
13. Ronco C, Inguaggiato P, D'Intini V, Cole L, Bellomo R, Poulin S, Bordoni V, Crepaldi C, Gastaldon F, Brendolan A, Trairak P, Khajohn T: The role of extracorporeal therapies in sepsis. J Nephrol 16(suppl 7):S34-S41, 2003
14. Ronco C, Brendolan A, Dan M, Piccinni P, Bellomo R, Wratten ML, Inguaggiato P, Tetta C: Use of sorbents in acute renal failure and sepsis. In: Ronco C, Winchester JF (eds). Dialysis, Dialyzers and Sorbents: Where Are We Going? Basel: Karger, 2001:180-193
15. Thakar CV, Yared JP, Nelson D, Paganini EP: Renal dysfunction and frequency of sepsis and serious infections after cardiac surgery. J Am Soc Nephrol 13:243A, 2002
16. Mehta RL: Sepsis influences outcomes from acute renal failure. J Am Soc Nephrol 13:246A, 2002
17. Jaber BL, Rao M, Guo D, Balakrishnan VS, Perianayagam MC, Freeman RB, Pereira BJ: Cytokine gene promoter polymorphisms and mortality in acute renal failure. Cytokine 25:212-219, 2004
18. Schetz M: Non-renal indications for continuous renal replacement therapy. Kidney Int Suppl 56:S88-S94, 2002
19. Schor N: Acute renal failure and the sepsis syndrome. Kidney Int 61:764-776, 2002
20. Ronco C, Tetta C, Mariano F, Wratten ML, Bonello M, Bordoni V, Cardona X, Inguaggiato P, Pilotto L, d'Intini V, Bellomo R: Interpreting the mechanisms of continuous renal replacement therapy in sepsis: the peak concentration hypothesis. Artif Organs 27:792-801, 2003
21. Ronco C, Bonello M, Bordoni V, Ricci Z, d'Intini V, Bellomo R, Levin NW: Extracorporeal therapies in non-renal disease: treatment of sepsis and the peak concentration hypothesis. Blood Purif 22:164-174, 2004
22. Tetta C, Bellomo R, Ronco C: Artificial organ treatment for multiple organ failure, acute renal failure, and sepsis: recent new trends. Artif Organs 27:202-213, 2003
23. McMaster P, Shann F: The use of extracorporeal techniques to remove humoral factors in sepsis. Pediatr Crit Care Med 4:2-7, 2003
24. Reiter K, D'Intini V, Bordoni V, Baldwin I, Bellomo R, Tetta C, Brendolan A, Ronco C: High-volume hemofiltration in sepsis: theoretical basis and practical application. Nephron 92:251-258, 2002
25. De Vriese AS, Colardyn FA, Philippe JJ, Vanholder RC, De Sutter JH, Lameire NH: Cytokine removal during continuous hemofiltration in septic patients. J Am Soc Nephrol 10:846-853, 1999
26. Ronco C, Bellomo R, Homel P, Brendolan A, Dan M, Piccinni P, La Greca G: Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: a prospective randomised trial. Lancet 356:26-30, 2000
27. Bellomo R: Preliminary experience with high volume HF in human septic shock. Kidney Int Suppl 66:S182-S185, 1998
28. Bellomo R, Baldwin I, Ronco C: High-volume hemofiltration. Contrib Nephrol 132:375-382, 2001
29. Brendolan A, D'Intini V, Ricci Z, Bonello M, Ratanarat R, Salvatori G, Bordoni V, De Cal M, Andrikos E, Ronco C: Pulse high volume hemofiltration. Int J Artif Organs 27:398-403, 2004
30. Morgera S, Slowinski T, Melzer C, Sobottke V, Vargas-Hein O, Volk T, Zuckermann-Becker H, Wegner B, Muller JM, Baumann G, Kox WJ, Bellomo R, Neumayer HH: Renal replacement therapy with high-cutoff hemofilters: impact of convection and diffusion on cytokine clearances and protein status. Am J Kidney Dis 43:444-453, 2004
31. Uchino S, Bellomo R, Goldsmith D, Davenport P, Cole L, Baldwin I, Panagiotopoulos S, Tipping P: Super high flux hemofiltration: a new technique for cytokine removal. Intensive Care Med 28:651-655, 2002
32. Honore PM, Jamez J, Wauthier M, Lee PA, Dugernier T, Pirenne B, Hanique G, Matson JR: Prospective evaluation of short-term, high-volume isovolemic hemofiltration on the hemodynamic course and outcome in patients with intractable circulatory failure resulting from septic shock. Crit Care Med 28:3581-3587, 2000
33. Honore PM, Matson JR: Short-term high-volume hemofiltration in sepsis: perhaps the right way is to start with. Crit Care Med 30:1673-1674, 2002
34. Journois D, Israel-Biet D, Pouard P, Rolland B, Silvester W, Vouhe P, Safran D: High-volume, zero-balanced hemofiltration to reduce delayed inflammatory response to cardiopulmonary bypass in children. Anesthesiology 85:965-976, 1996
35. Oudemans-van Straaten HM, Bosman RJ, van der Spoel JI, Zandstra DF: Outcome of critically ill patients treated with intermittent high volume hemofiltration: a prospective cohort analysis. Intensive Care Med 25:814-821, 1999
36. Lonnemann G, Bechstein M, Linnenweber S, Burg M, Koch KM: Tumor necrosis factor-alpha during continuous high-flux hemodialysis in sepsis with acute renal failure. Kidney Int Suppl 72:S84-S87, 1999
37. Yekebas EF, Eisenberger CF, Ohnesorge H, Saalmuller A, Elsner HA, Engelhardt M, Gillesen A, Meins J, The M, Strate T, Busch C, Knoefel WT, Bloechle C, Izbicki JR: Attenuation of sepsis-related immunoparalysis by continuous veno-venous hemofiltration in experimental porcine pancreatitis. Crit Care Med 29:1423-1430, 2001
38. Yekebas EF, Strate T, Zolmajd S, Eisenberger CF, Erbersdobler A, Saalmuller A, Steffani K, Busch C, Elsner HA, Engelhardt M, Gillesen A, Meins J, The M, Knoefel WT, Izbicki JR: Impact of different modalities of continuous venovenous hemofiltration on sepsis-induced alterations in experimental pancreatitis. Kidney Int 62:1806-1818, 2002
39. Cole L, Bellomo R, Hart G, Journois D, Davenport P, Tipping P, Ronco C: A phase II randomized, controlled trial of continuous hemofiltration in sepsis. Crit Care Med 30:100-106, 2002
40. Bouman CS, Oudemans-van Straaten HM, Tijssen JG, Zandstra DF, Kesecioglu J: Effects of early high-volume continuous venovenous hemofiltration on survival and recovery of renal function in intensive care patients with acute renal failure: a prospective, randomized trial. Crit Care Med 30:2205-2211, 2002
41. Sander A, Armbruster W, Sander B: Hemofiltration increases IL-6 clearance in early systemic inflammatory response syndrome but does not alter IL-6 and TNF alpha plasma concentrations. Intensive Care Med 23:878-884, 1997
42. Sanchez-Izquierdo JA, Perez Vela JL, Lozano Quintana MJ, Alted Lopez E, Ortuno de Solo B, Ambros Checa A: Cytokines clearance during venovenous hemofiltration in the trauma patient. Am J Kidney Dis 30:483-488, 1997
43. Cardigan R, McGloin H, Mackie I, Machin S, Singer M: Endothelial dysfunction in critically ill patients: the effect of haemofiltration. Intensive Care Med 24:1264-1271, 1998
44. Kellum JA, Johnson JP, Kramer D, Palevsky P, Brady J, Pinsky M: Diffuse vs. convective therapy: effects on mediators of inflammation in patients with severe systemic inflammatory response syndrome. Crit Care Med 26:1995-2000, 1998
45. Misset B, Timsit JF, Chevret S, Renaud B, Tamion F, Carlet J: A randomized cross-over comparison of the hemodynamic response to intermittent hemodialysis and continuous hemofiltration in ICU patients with acute renal failure. Intensive Care Med 22:742-746, 1996
46. Swartz RD, Messana JM, Orzol S, Port FK: Comparing continuous hemofiltration with hemodialysis in patients with severe acute renal failure. Am J Kidney Dis 34:424-432, 1999
47. Ronco C, Brendolan A, Lonnemann G, Bellomo R, Piccinni P, Digito A, Dan M, Irone M, La Greca G, Inguaggiato P, Maggiore U, De Nitti C, Wratten ML, Ricci Z, Tetta C: A pilot study of coupled plasma filtration with adsorption in septic shock. Crit Care Med 30:1250-1255, 2002
48. Formica M, Olivieri C, Livigni S, Cesano G, Vallero A, Maio M, Tetta C: Hemodynamic response to coupled plasmafiltration-adsorption in human septic shock. Intensive Care Med 29:703-708, 2003
49. Stegmayr BG, Banga R, Berggren L, Norda R, Rydvall A, Vikerfors T: Plasma exchange as rescue therapy in multiple organ failure including ARF. Crit Care Med 31:1730-1736, 2003
50. Berlot G, Tomasini A, Silvestri L, Gullo A: Plasmapheresis in the critically ill patient. Kidney Int Suppl 66:S178-S181, 1998
51. Reeves JH, Butt WW, Shann F, Layton JE, Stewart A, Waring PM, Presneill JJ: Continuous plasmafiltration in sepsis syndrome. Plasmafiltration in Sepsis Study Group. Crit Care Med 27:2096-2104, 1999
52. Wratten ML, Brendolan A, Ronco C, La Greca G, Tetta C: Should we target signal pathways instead of single mediators in the treatment of sepsis? Contrib Nephrol 132:400-414, 2001
53. Better OS, Stein JH: Early management of shock and prophylaxis of acute renal failure in traumatic rhabdomyolysis. N Engl J Med 322:825-829, 2002
54. Bywaters EG, Beall D: Crush injuries with impairment of renal function. 1941. J Am Soc Nephrol 9:322-332, 1998
55. Vanholder R, Sever MS, Erek E, Lameire N: Rhabdomyolysis. J Am Soc Nephrol 11:1553-1561, 2000
56. Zager RA: Rhabdomyolysis and myohemoglobinuric acute renal failure. Kidney Int 46:314-376, 2002
57. Holt SG, Moore KP: Pathogenesis and treatment of renal dysfunction in rhabdomyolysis. Intensive Care Med 27:803-811, 2001
58. Rice EK, Isbel NM, Becker GJ, Atkins RC, McMahon LP: Heroin overdose and myoglobinuric acute renal failure. Clin Nephrol 54:449-454, 2000
59. Szpirt WM: Plasmapheresis is not justified in treatment of rhabdomyolysis and acute renal failure. J Cardiovasc Surg (Torino) 38:557, 1997
60. Amyot SL, Leblanc M, Thibeault Y, Geadah D, Cardinal J: Myoglobin clearance and removal during continuous venovenous hemofiltration. Intensive Care Med 25:1169-1172, 1999
61. Nicolau D, Feng YS, Wu AH, Bernstein SP, Nightingale CH: Myoglobin clearance during continuous veno-venous hemofiltration with or without dialysis. Int J Artif Organs 21:205-209, 1998
62. Perez-Vela JL, Sanchez CM, Sanchez-Izquierdo Riera JA, Ambros Checa A, Caballero Cubedo R, Alted Lopez E: Neuroleptic malignant syndrome in a patient with head injury. Intensive Care Med 22:593-595, 1996
63. Winterberg B, Ramme K, Tenschert W, Winterberg G, Rolf N, Wendt M, Teerling K, Lison AE, Zumkley H: Hemofiltration in myoglobinuric acute renal failure. Int J Artif Organs 13:113-116, 1990
64. Schenk MR, Beck DH, Nolte M, Kox WJ: Continuous veno-venous hemofiltration for the immediate management of massive rhabdomyolysis after fulminant malignant hyperthermia in a bodybuilder. Anesthesiology 94:1139-1141, 2001
65. Bastani B, Frenchie D: Significant myoglobin removal during continuous veno-venous haemofiltration using F80 membrane. Nephrol Dial Transplant 12:2035-2036, 1997
66. Berns JS, Cohen RM, Rudnick MR: Removal of myoglobin by CAVH-D in traumatic rhabdomyolysis. Am J Nephrol 11:73, 1991
67. Bellomo R, Daskalakis M, Parkin G, Boyce N: Myoglobin clearance during acute continuous hemodiafiltration. Intensive Care Med 17:509, 1991
68. Wakabayashi Y, Kikuno T, Ohwada T, Kikawada R: Rapid fall in blood myoglobin in massive rhabdomyolysis and acute renal failure. Intensive Care Med 20:109-112, 1994
69. Shigemoto T, Rinka H, Matsuo Y, Kaji A, Tsukioka K, Ukai T, Shimaoka H: Blood purification for crush syndrome. Ren Fail 19:711-719, 1997
70. Bywaters EG, Stead JK: The production of renal failure following injection of solution containing myoglobin. Q J Exp Physiol 33:53-70, 1994
71. Woodrow G, Brownjohn AM, Turney JH: The clinical and biochemical features of acute renal failure due to rhabdomyolysis. Ren Fail 17:467-474, 1995
72. Oda Y, Shindoh M, Yukioka H, Nishi S, Fujimori M, Asada A: Crush syndrome sustained in the 1995 Kobe, Japan, earthquake; treatment and outcome. Ann Emerg Med 30:507-512, 1997
73. Rokyta R Jr, Matejovic M, Krouzecky A, Opatrny K Jr, Ruzicka J, Novak I: Effects of continuous venovenous haemofiltration-induced cooling on global haemodynamics, splanchnic oxygen and energy balance in critically ill patients. Nephrol Dial Transplant 19:623-630, 2004
74. Yagi N, Leblanc M, Sakai K, Wright EJ, Paganini EP: Cooling effect of continuous renal replacement therapy in critically ill patients. Am J Kidney Dis 32:1023-1030, 1998
75. Marenzi G, Lauri G, Grazi M, Assanelli E, Campodonico J, Agostoni P: Circulatory response to fluid overload removal by extracorporeal ultrafiltration in refractory congestive heart failure. J Am Coll Cardiol 38:963-968, 2001
76. Kishore KK: Renal replacement therapy in congestive heart failure. Semin Dial 10:259-266, 1997
77. Agostino P, Marenzi G, Lauri G, Perego G, Schianni M, Sganz-Erla P, Guazzi MD: Sustained improvement in functional capacity after removal of body fluid with isolated ultrafiltration in chronic cardiac insufficiency. Am J Med 96:191-199, 1994
78. Blake P, Paganini EP: Refractory congestive heart failure: overview and application of extracorporeal ultrafiltration. Adv Ren Replace Ther 3:166-173, 1996
79. Blake P, Hasegawa Y, Khosla MC, Fouad-Tarazi F, Sakura N, Paganini EP: Isolation of "myocardial depressant factor(s)" from the ultrafiltrate of heart failure patients with acute renal failure. ASAIO J 42:M911-M915, 1996
80. Agostini P: Sustained benefit from ultrafiltration in moderate congestive heart failure. Cardiology 96:183-189, 2001
81. Canaud B, Leray-Moragues H, Garred LJ,: Slow isolated ultrafiltration for the treatment of congestive heart failure. Am J Kidney Dis 28(suppl 3):S67-S73, 1996
82. Ronco C, Ricci Z, Bellomo R, Bedogni F: Extracorporeal ultrafiltration for the treatment of overhydration and congestive heart failure. Cardiology 96:155-168, 2001
83. Brause M, Deppe CE, Hollenbeck M, Ivens K, Schoebel FC, Grabensee B, Heering P: Congestive heart failure as an indication for continuous renal replacement therapy. Kidney Int Suppl 72:S95-S98, 1999
84. Rimondini A, Cipolla CM, Della Bella P, Grazi S, Sisillo E, Susini G, Guazzi MD: Hemofiltration as short-term treatment for refractory congestive heart failure. Am J Med 83:43-48, 1987
85. Iorio L, Simonelli R, Nacca GR, DeSanto LS: Daily hemofiltration in severe heart failure. Kidney Int 51:62-65, 1997
86. Biasioli S, Barbaresi F, Barbiero M, Petrosino L, Cavallini L, Zambello A, Cavalcanti G, Foroni R, Bonofiglio C: Intermittent venovenous hemofiltration as a chronic treatment for refractory and intractable heart failure. Am Soc Artif Intern Organs 38:M658-M663, 1992
87. Coraim FI, Wolner E: Continuous hemofiltration for the failing heart. New Horiz 3:725-731, 1995
88. Inoue T, Sakai Y, Morooka S, Takayanagi K, Hayashi T, Takabatake Y: Hemofiltration as a treatment for patients with refractory heart failure. Clin Cardiol 15:514-518, 1992
89. Chapman A, Rotellar C, Mackow RC, Hanson K: Continuous arteriovenous hemofiltration in patients with severe congestive heart failure. Am J Med 83:1167-1168, 1997
90. Kramer P, Wigger W, Rieger J, Scheler F: A new and simple method for treatment of over-hydrated patients resistant to diuretics. Klin Wochenschr 55:1121-1122, 1977
91. Simpson IA, Rae AP, Simpson K, Gribben J, Boulton Jones JM, Allison ME, Hutton I: Ultrafiltration in the management of refractory congestive heart failure. Br Heart J 55:344-347, 1985
92. Agostino P, Marenzi G, Pepi M, Doria E, Salvioni A, Perego G, Schianni M, Lauri G, Giraldi F, Grazi S, Guazzi MD: Isolated ultrafiltration in moderate congestive heart failure. J Am Coll Cardiol 21:424-431, 1993
93. Forslund T, Ridderwald F, Fauchald P, Torvik D, Fyhrquist F, Simons S: Hormonal changes in patients with severe chronic congestive heart failure treated by ultrafiltration. Nephrol Dial Transplant 7:306-310, 1992
94. Tormey V, Conlon PJ, Farrel J, Horgan J, Walshe JJ: Long-term successful management of refractory congestive cardiac failure by intermittent ambulatory peritoneal ultrafiltration. Q J Med 89:683, 1996
95. Marenzi G, Grazi S, Giraldi F, Lauri G, Perego G, Guazzi M, Salvioni A, Guazzi MD: Interrelation of humoral factors, hemodynamics, and fluid and salt metabolism in congestive heart failure: effects of extracorporeal ultrafiltration. Am J Med 94:49-56, 1993
96. Baudouin SV, Wiggins J, Keogh BF, Morgan CJ, Evans TW: Continuous veno-venous hemofiltration following cardio-pulmonary bypass. Intensive Care Med 19:290-293, 1993
97. Bent P, Tan HK, Bellomo R, Buckmaster J, Doolan L, Hart G, Silvester W, Gutteridge G, Matalanis G, Raman J, Rosalion A, Buxton BF: Early and intensive continuous hemofiltration for severe renal failure after cardiac surgery. Ann Thorac Surg 71:832-837, 2001
98. Kumar A, Brar R, Wang P, Dee L, Skorupa G, Khadour F, Schulz R, Parrillo JE: Role of nitric oxide and cGMP in human septic serum-induced depression of cardiac myocyte contractility. Am J Physiol 276:R265-R276, 1999
99. Bellomo R, Raman J, Ronco C: Intensive care unit management of the critically ill patient with fluid overload after open heart surgery. Cardiology 96:169-176, 2001
100. Bellomo R, McGrath B, Boyce N: Effect of continuous venovenous hemofiltration with dialysis on hormone and catecholamine clearance in critically ill patients with acute renal failure. Crit Care Med 22:833-837, 1994
101. Handley HH, Gorsuch R, Levin NW, Ronco C: Intravenous catheter for intracorporeal plasma filtration. Blood Purif 20:61-69, 2002
102. Eckardt KU: Renal failure in liver disease. Intensive Care Med 25:5-14, 1999
103. Epstein M: Hepatorenal syndrome in the kidney in liver disease. In: Epstein M (ed). The Kidney in Liver Disease. Philadelphia: Hanley and Belfus, 1996:75-108
104. Green J, Better OS: Circulatory disturbance and renal dysfunction in liver disease and in obstructive jaundice. Isr J Med Sci 30:48-65, 1994
105. Kaplan AA, Epstein M: Extracorporeal blood purification in the management of patients with hepatic failure. Semin Nephrol 17:576-582, 1997
106. Ellis D, Avner ED: Renal failure and dialysis therapy in children with hepatic failure in the perioperative period of orthotopic liver transplantation. Clin Nephrol 25:295-303, 1986
107. Sandy D, Charles R, Kozlowski L: Acute dialytic support in patients with end-stage liver disease awaiting liver transplantation. J Am Soc Nephrol 7:1462A, 1996
108. Perez GO:. In: Epstein M (ed). The Kidney in Liver Disease. Philadelphia: Hanley and Belfus, 1996:517-528
109. Davenport A: Ultrafiltration in diuretic-resistant volume overload in nephrotic syndrome and patients with ascites due to chronic liver disease. Cardiology 96:190-195, 2001
110. Matsubara S, Okabe K, Ouchi K, Miyazaki Y, Yajima Y, Suzuki H, Otsuki M, Matsuno S: Continuous removal of middle molecules by hemofiltration in patients with acute liver failure. Crit Care Med 18:1331-1338, 1990
111. Mitzner SR, Stange J, Klammt S, Peszynski P, Schmidt R, Noldge-Schomburg G: Extracorporeal detoxification using the molecular adsorbent recirculating system for critically ill patients with liver failure. J Am Soc Nephrol 12(suppl 17):S75-S82, 2001
112. Awad SS, Swaniker F, Alarcon W, Posner S, Haft J, Bartlett RH: Preliminary results of a phase I trial evaluating a non-cell based extracorporeal hepatic support device. ASAIO J 46:220, 2000
113. Novelli G, Rossi M, Pretagostini R, Iappelli M, Poli L, Della Pietra F, Della Rocca G, Berlocco P, Di Nicuolo A, Peritore D, Colonnello M, Cancrini C, Attili AM, Cortesini R: Use of MARS in the treatment of acute liver failure: preliminary monocentric experience. ASAIO J 46:234, 2000
114. Stange J, Mitzner SR, Risler T, Erley CM, Lauchart W, Goehl H, Klammt S, Peszynski P, Freytag J, Hickstein H, Löhr M, Liebe S, Scharek W, Hopt UT, Schmidt R: Molecular adsorbent recycling system (MARS): clinical results of a new membrane-based blood purification system for bioartificial liver support. Artif Organs 23:319-330, 1999
115. Mitzner SR, Stange J, Klammt S, Risler T, Erley CM, Bader BD, Berger ED, Lauchart W, Peszynski P, Freytag J, Hickstein H, Loock J, Lohr JM, Liebe S, Emmrich J, Korten G, Schmidt R: Improvement of hepatorenal syndrome with extracorporeal albumin dialysis MARS: results of a prospective, randomized, controlled clinical trial. Liver Transpl 6:277-286, 2000
116. Stange J, Mitzner SR, Klammt S, Freytag J, Peszynski P, Loock J, Hickstein H, Korten G, Schmidt R, Hentschel J, Schulz M, Lohr M, Liebe S, Schareck W, Hopt UT: Liver support by extracorporeal blood purification: a clinical observation. Liver Transpl 6:603-613, 2000
117. Schmidt LE, Sorensen VR, Svendsen LB, Larsen FS, Stange J, Hansen BA: Improvement of systemic vascular resistance and arterial pressure in patients with acute or chronic liver failure during treatment with the molecular adsorbent recycling system (MARS). Hepatology 32:401A, 2000
118. Kreymann B, Seige M, Schweigart U, Kopp KF, Classen M: Albumin dialysis: effective removal of copper in a patient with fulminant Wilson disease and successful bridging to liver transplantation: a new possibility for the elimination of protein-bound toxins. J Hepatol 31:1080-1085, 1999
119. Ash SR: Extracorporeal blood detoxification by sorbents in treatment of hepatic encephalopathy. Adv Ren Replace Ther 9:3-18, 2002
120. Jost U: Einsatz eines zellfreien Leberunterstutzungssystems zur Elimination albumin-gebundener toxischer Substanzen beim akuten Leberversagen. Germ Interdisciplin J Intensive Care Med 37:435, 2000
121. Chawla L, Georgescu F, Abell B, et al. Modification of CVVHDF with single-pass albumin dialysate allows for removal of serum bilirubin. Am J Kidney Dis 45:e51-6, 2005
122. Ash SR: Extracorporeal blood detoxification by sorbents in treatment of hepatic encephalopathy. Adv Ren Replace Ther 9:3-18, 2002
123. Ash SR, Blake DE, Carr DJ, Carter C, Howard T, Makowka L: Clinical effects of a sorbent suspension dialysis system in treatment of hepatic coma (the BioLogic-DT). Int J Artif Organs 15:151-161, 1992
124. Ash SR: Hemodiabsorption in treatment of acute hepatic failure and chronic cirrhosis with ascites. Artif Organs 18:355-362, 1994
125. Wilkinson AH, Ash SR, Nissenson AR: Hemodiabsorption in treatment of hepatic failure. J Transpl Coord 8:43-50, 1998
126. Hughes RD, Pucknell A, Routley D, Langley PG, Wendon JA, Williams R: Evaluation of the BioLogic-DT sorbent-suspension dialyser in patients with fulminant hepatic failure. Int J Artif Organs 17:657-662, 1994
127. Ellis AJ, Hughes RD, Nicholl D, Langley PG, Wendon JA, O'Grady JG, Williams R: Temporary extracorporeal liver support for severe acute alcoholic hepatitis using the BioLogic-DT. Int J Artif Organs 22:27-34, 1999
128. Mazariegos GV, Ash SR, Patzer JF: Preliminary results: randomized clinical trial of the BioLogic-DT in treatment of acute hepatic failure (AHF) with coma. Artif Organs 21:529, 1997
129. Kramer L, Gendo A, Madl C, Ferrara I, Funk G, Schenk P, Sunder-Plassmann G, Horl WH: Biocompatibility of a cuprophane charcoal-based detoxification device in cirrhotic patients with hepatic encephalopathy. Am J Kidney Dis 36:1193-1200, 2000
130. O'Grady JG, Gimson AE, O'Brien CJ, Pucknell A, Hughes RD, Williams R: Controlled trials of charcoal hemoperfusion and prognostic factors in fulminant hepatic failure. Gastroenterology 94:1186-1192, 1988
131. Omokawa S, Yamashita M, Malchesky PS, Koo AP, Matsushita M, Nose Y: Therapeutic plasmapheresis for cholestatic liver diseases: study of 9 cases. Prog Clin Biol Res 337:233-236, 1990
132. Lepore MJ, Stutman LJ, Bonanno CA, Conklin EF, Robilotti JG Jr, McKenna PJ: Plasmapheresis with plasma exchange in hepatic coma. II. Fulminant viral hepatitis as a systemic disease. Arch Intern Med 129:900-907, 1972
133. Lepore MJ, Martel AJ: Plasmapheresis with plasma exchange in hepatic coma. Methods and results in five patients with acute fulminant hepatic necrosis. Ann Intern Med 72:165-174, 1970
134. Yoshiba M, Inoue K, Sekiyama K, Koh I: Favorable effect of new artificial liver support on survival of patients with fulminant hepatic failure. Artif Organs 20:1169-1172, 1996
135. Sadamori H, Yagi T, Inagaki M, Shima Y, Matsuda H, Tanaka N, Sakaguchi K, Tsuji T, Matsumi M, Katayama H, Hirakawa N: High-flow-rate haemodiafiltration as a brain-support therapy proceeding to liver transplantation for hyperacute fulminant hepatic failure. Eur J Gastroenterol Hepatol 14:435-439, 2002
136. Sadahiro T, Hirasawa H, Oda S, Shiga H, Nakanishi K, Kitamura N, Hirano T: Usefulness of plasma exchange plus continuous hemodiafiltration to reduce adverse effects associated with plasma exchange in patients with acute liver failure. Crit Care Med 29:1386-1392, 2001
137. Zager RA: Acute renal failure in the setting of bone marrow transplantation. Kidney Int 46:1443-1458, 1994
138. Bowman WP, Shuster JC, Bhem F, et al.: Improved survival for children with B cell (sIg+) acute lymphoblastic leukemia (B-ALL) and stage IV small non-cleaved cell lymphoma. Proc Am Soc Clin Oncol 11:277, 1992
139. Griffin TC, Bowman WP, Winick NJ, Buchanan GR: Treatment of advanced stage diffuse, small non-cleaved cell lymphoma in childhood: further experience with total therapy B. Med Pediatr Oncol 23:393-399, 1994
140. Saccente SL, Kohaut EC, Berkow RL: Prevention of tumor lysis syndrome using continuous veno-venous hemofiltration. Pediatr Nephrol 9:569-573, 1995
141. Sakarcan A: Hyperphosphatemia in tumor lysis syndrome, role of hemodialysis and continuous veno-venous HF. Pediatr Nephrol 8:351-353, 1994
142. Pepe PE, Potkin RT, Reus DH: Clinical predictors of the adult respiratory distress syndrome. Am J Surg 144:124-130, 1982
143. Barzilay E, Kessler D, Berlot G, Gullo A, Geber D, Ben Zeev I: Use of extracorporeal supportive techniques as additional treatment for septic-induced multiple organ failure patients. Crit Care Med 17:634-637, 1989
144. Coraim FJ, Coraim HP, Ebermann R, Stellwag FM: Acute respiratory failure after cardiac surgery: clinical experience with the application of continuous arteriovenous hemofiltration. Crit Care Med 14:714-718, 1986
145. Laggner AN, Druml W, Lenz K, Schneeweiss B, Grimm G: Influence of ultrafiltration/hemofiltration on extravascular lung water. Contrib Nephrol 93:65-70, 1991
146. Cosentino F, Paganini E, Lockrem J, Stoller J, Wiedemann H: Continuous arteriovenous hemofiltration in the adult respiratory distress syndrome. A randomized trial. Contrib Nephrol 93:94-97, 1991
147. Humphrey H, Hall J, Sznajder I, Silverstein M, Wood L: Improved survival in ARDS patients associated with a reduction in pulmonary capillary wedge pressure. Chest 97:1176-1180, 1990
148. Rabb H, Wang Z, Nemoto T, Soleimani M: Downregulation of the water channel aquaporin 5 in the lung following renal ischemic reperfusion injury occurs independent of reperfusion products. J Am Soc Nephrol 10:639A, 1999
149. Rabb H, Chamoun F, Hotchkiss J: Molecular mechanisms underlying combined kidney-lung dysfunction during acute renal failure. Contrib Nephrol 132:41-52, 2001
150. Bonventre JV: Pathophysiology of ischemic acute renal failure. Inflammation, lung-kidney cross-talk, and biomarkers. Contrib Nephrol 144:19-30, 2004
151. Chien CC, King LS, Rabb H: Mechanisms underlying combined acute renal failure and acute lung injury in the intensive care unit. Contrib Nephrol 144:53-62, 2004
152. Moonka R, Gentilello L: Hypothermia induced by continuous arteriovenous hemofiltration as a treatment for adult respiratory distress syndrome: a case report. J Trauma 40:1026-1028, 1996
153. Gruberg L, Mintz GS, Mehran R, Gangas G, Lansky AJ, Kent KM, Pichard AD, Satler LF, Leon MB: The prognostic implications of further renal function deterioration within 48 hours of interventional coronary procedures in patients with pre-existing chronic renal insufficiency. J Am Coll Cardiol 36:1542-1548, 2002
154. Albert SG, Shapiro MJ, Brown WW, Goodgold H, Zuckerman D, Durham R, Kern M, Fletcher J, Wolverson M, Plummer ES, et al.: Analysis of radiocontrast- induced nephropathy by dual-labeled radionuclide clearance. Invest Radiol 29:618-623, 1994
155. Murphy SW, Barrett BJ, Parfrey PS: Contrast nephropathy. J Am Soc Nephrol 11:177-182, 2000
156. McCullough PA, Wolyn R, Rocher LL, Levin RN, O'Neill WW: Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality. Am J Med 103:368-375, 1997
157. Liss P, Nygren A, Erikson U, Ulfendahl HR: Injection of low and iso-osmolar contrast medium decreases oxygen tension in the renal medulla. Kidney Int 53:698-702, 1998
158. Rudnick MR, Goldfarb S, Wexler L, Ludbrook PA, Murphy MJ, Halpern EF, Hill JA, Winniford M, Cohen MB, VanFossen DB: Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: a randomized trial. The Iohexol Cooperative Study. Kidney Int 47:254-261, 1995
159. Solomon R, Werner C, Mann D, D'Elia J, Silva P: Effects of saline, mannitol, and furosemide to prevent acute decreases in renal function induced by radiocontrast agents. N Engl J Med 331:1416-1420, 1994
160. Tepel MGM, Schwarzfeld C, Laufer U, Liermann D, Zidek W: Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine. N Engl J Med 343:180-184, 2000
161. Ix JH, McCulloch CE, Chertow GM: Theophylline for the prevention of radiocontrast nephropathy: a meta-analysis. Nephrol Dial Transplant 19:2747-2753, 2004
162. Merten GJ, Burgess WP, Gray LV, Holleman JH, Roush TS, Kowalchuk GJ, Bersin RM, Van Moore A, Simonton CA 3rd, Rittase RA, Norton HJ, Kennedy TP: Prevention of contrast-induced nephropathy with sodium bicarbonate: a randomized controlled trial. JAMA 291:2328-2334, 2004
163. Lehnert T, Keller E, Gondolf K, Schaffner T, Pavenstadt H, Schollmeyer P: Effect of hemodialysis after contrast medium administration in patients with renal insufficiency. Nephrol Dial Transplant 13:358-362, 1998
164. Moon SS, Back SE, Kurkus J, Nilsson Ehle P: Hemodialysis for elimination of the nonionic contrast medium iohexol after angiography in patients with impaired renal function. Nephron 70:430-437, 1995
165. Solomon R: Contrast-medium-induced acute renal failure. Kidney Int 53:230-242, 1998
166. Brooks MH, Barry KG: Removal of iodinated contrast material by peritoneal dialysis. Nephron 12:10-14, 1973
167. Ueda J, Furukawa T, Takahashi S, Sakaguchi K: Elimination of ioversol by hemodialysis. Acta Radiol 37:826-829, 1996
168. Waaler A, Svaland M, Fauchald P, Jakobsen JA, Kolmannskog F, Berg KJ: Elimination of iohexol, a low osmolar nonionic contrast medium, by hemodialysis in patients with chronic renal failure. Nephron 56:81-85, 1990
169. Matzkies FK, Reinecke H, Tombach B, Kosch M, Hegger K, Milius M, Hohage H, Kisters K, Kerber S, Schaefer RM: Influence of dialysis procedure, membrane surface and membrane material on iopromide elimination in patients with reduced kidney function. Am J Nephrol 20:300-304, 2000
170. Furukawa T, Ueda J, Takahashi S, Sakaguchi K: Elimination of low osmolality contrast media by hemodialysis. Acta Radiol 37:966-971, 1996
171. Vogt B, Ferrari P, Schonholzer C, Marti HP, Mohaupt M, Wiederkehr M, Cereghetti C, Serra A, Huynh-Do U, Uehlinger D, Frey FJ: Prophylactic hemodialysis after radiocontrast media in patients with renal insufficiency is potentially harmful. Am J Med 111:692-698, 2001
172. Marenzi G, Marana I, Lauri G, Assanelli E, Grazi M, Campodonico J,
173. Yang CW, Kim YS, Park IS, Chang YS, Yoon YS, Bang BK: Treatment of severe acute hypernatremia and renal failure by hemodialysis. Nephron 70:372-373, 1995
174. Chai J, Diao L, Sheng Z, Guo Z, Gao W, Jia X: Heparin-free hemodialysis in the treatment of hypernatremia in severely burned patients. Burns 26:634-637, 2000
175. Pazmino PA, Pazmino BP: Treatment of acute hypernatremia with hemodialysis. Am J Nephrol 13:260-265, 1993
176. Lin JJ, McKenney DW, Price C, Morrison RR, Novotny WE: Continuous venovenous hemodiafiltration in hypernatremic hyperglycemic nonketotic coma. Pediatr Nephrol 17:969-973, 2002
177. Davenport A: Renal replacement therapy in the patient with acute brain injury. Am J Kidney Dis 37:457-466, 2001
178. Winney RJ, Kean DM, Best JJ, Smith MA: Changes in brain water with haemodialysis. Lancet 2:1107-1108, 1986
179. Ronco C, Bellomo R, Brendolan A, Pinna V, La Greca G: Brain density changes during renal replacement in critically ill patients with acute renal failure. Continuous hemofiltration versus intermittent hemodialysis. J Nephrol 12:173-178, 1999
180. Kennedy AC, Linton AL, Luke RG, Renfrew S, Dinwoodie A: The pathogenesis and prevention of cerebral dysfunction during dialysis. Lancet 1:790-793, 1964
181. Arieff AI, Guisado R, Massry SG, Lazarowitz VC: Central nervous system pH in uremia and the effects of hemodialysis. J Clin Invest 58:306-311, 1976
182. Arieff AI: Dialysis disequilibrium syndrome. current concepts on pathogenesis and prevention. Kidney Int 45:629-635, 1994
183. Rosen F, Nichol CA: Studies on the nature and specificity of the induction of several adaptive enzymes responsive to cortisol. Adv Enzyme Regul 2:115-135, 1964
184. Goldsmith DJA, Forni LG, Hilton PJ: Bicarbonate therapy and intracellular acidosis. Clin Sci 93:593-598, 1997
185. Davenport A, Will EJ, Davison AM: Early changes in intracranial pressure during haemofiltration treatment in patients with grade 4 hepatic encephalopathy and acute oliguric renal failure. Nephrol Dial Transplant 5:192-198, 1990
186. Davenport A: The management of renal failure in patients at risk of cerebral edema/hypoxia. New Horiz 3:717-724, 1995
187. Jost CM, Agarwal R, Khair-el-Din T, Grayburn PA, Victor RG, Henrich WL: Effects of cooler temperature dialysate on hemodynamic stability in "problem" dialysis patients. Kidney Int 44:606-612, 1993
188. Davenport A: Renal replacement therapy in the patient with acute brain injury. Am J Kidney Dis 30:S20-S27, 1996
189. Ward DM: The approach to anticoagulation in patients treated with extracorporeal therapy in the intensive care unit. Adv Ren Replace Ther 4:160-173, 1997
190. Ohtake Y, Hirasawa H, Sugai T, Oda S, Shiga H, Matsuda K, Kitamura N: Nafamostat mesylate as anticoagulant in continuous hemofiltration and continuous hemodiafiltration. Contrib Nephrol 93:215-217, 1991
191. Davenport A, Will EJ, Davison AM: The effect of prostacyclin on intracranial pressure in patients with acute hepatic and renal failure. Clin Nephrol 35:151-157, 1991
192. Benjamin E: Continuous venovenous hemofiltration with dialysis and lactate clearance in critically ill patients. Crit Care Med 25:4-5, 1997
193. Bellomo R: Bench to bedside review: lactate and the kidney. Crit Care 6:322-326, 2002
194. Mizock BA, Falk JL: Lactic acidosis in critical illness. Crit Care Med 20:80-93, 1992
195. Madias NE: Lactic acidosis. Kidney Int 29:752-774, 1986
196. Levraut J, Ciebiera JP, Jambou P, Ichai C, Labib Y, Grimaud D: Effect of continuous venovenous hemofiltration with dialysis on lactate clearance in critically ill patients. Crit Care Med 25:58-62, 1997
197. Barton IK, Streather CP, Hilton PJ, Bradley RD: Successful treatment of severe lactic acidosis by haemofiltration using a bicarbonate-based replacement fluid. Nephrol Dial Transplant 6:368-370, 1991
198. Kirschbaum B, Galishoff M, Reines HD: Lactic acidosis treated with continuous hemodiafiltration and regional citrate anticoagulation. Crit Care Med 20:349-353, 1990
199. Forni G, Darling K, Evans M, Hilton PJ, Treacher DF: Lactate intolerance with continuous venovenous hemofiltration: the role of bicarbonate-buffered hemofiltration. Clin Intensive Care 9:40-42, 1998